Trial intelligence / Profile preview

Modafinil for fatigue and daytime sleepiness in cancer patients (preliminary study)

KCT0001412Phase 4Recruiting

Sponsor
JW Pharmaceutical Corporation
Start
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of modafinil in Nonhematologic neoplasms, sponsored by JW Pharmaceutical Corporation. Started Nov 2014; status: recruiting.

02

Drugs

modafinil
03

Conditions

Nonhematologic neoplasms

Beyond the preview

Go deeper on KCT0001412.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0001412.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call